Nvidia Earnings Spotlight Jensen Huangs Commentary on China and US Policy in Focus Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Repo Rate May Hit Decade Low Japans Megabanks Post Record Profits but Analysts Warn of Slowing Growth Amid Rising Credit Costs and Geopolitical Risks Jim Cramer Advises Investors to Focus on Upside Potential Not Past Stock Performance Consumer Credit Growth Accelerates in December Signaling Robust Holiday Spending Reddit Shares Slide Nearly 6 After Meta Launches New Forum App Intensifying Competitive Pressure DVLT Q1 2026 Earnings EPS Misses Estimates Amid Continued Operating Losses AerCap Holdings AER Q1 2026 Earnings EPS Surges Past Estimates by 4294 Shares Dip Slightly NBTB Q1 2026 Earnings EPS Misses Estimates Shares Hold Steady UBS Q1 2026 Earnings EPS Surpasses Expectations Stock Rises 175 Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus RideNow Group Inc Q1 2026 Earnings Narrower Loss Beats Expectations as Stock Slips Charlton Aria Acquisition Rights CHARR Plunge on Heavy Selling Rights May Approach Expiration Guidewire Software GWRE Retreats from Resistance Key Levels to Watch One Liberty Properties OLP Holds Steady Near Support as Real Estate Sector Faces Headwinds Medifast MED Shares Edge Lower Amid Consolidation Near Support Levels Verizon VZ Holds Near 48 Amid Modest Decline Consolidating Within Key Range NeOnc Technologies Holdings NTHI Holds Near Support as Modest Decline Tests Key Level Coca Cola Femsa KOF Holds Near Midpoint as Stock Slips 076 Starry Sea Acquisition Corp Rights SSEAR Holds Steady at 017 Amid Low Activity AZZ Inc Nudges Higher Maintains Position Above Key Support OPP Edges Higher Amid Steady Volume Key Levels in Focus for RiverNorthDoubleLine Strategic Opportunity Fund Defi Technologies DEFT Tests Support at 066 After 21 Decline Key Levels in Focus India Captures Data Center Growth Despite Limited Direct AI Chip Sector Exposure American Outdoor Brands Inc AOUT Q1 2026 Earnings Strong EPS Beat Driven by Operational Improvements Immunome Inc IMNM Rises Nearly 2 as Support Holds Resistance in Sight